Recombivax Hb 40 mcg (Hepatitis B Surface Antigen (Recombinant)) Suspension

RECOMBIVAX HB 40 MCG is a hepatitis B vaccine designed to prevent infection. This recombinant suspension is administered intramuscularly for broad immunity support.

RECOMBIVAX HB 40 MCG is used to stimulate the production of antibodies against hepatitis B virus. It is commonly administered to individuals at risk of exposure or those requiring long-term protection. This vaccine is part of a preventive healthcare strategy to reduce the risk of hepatitis B infection.

Common effects of RECOMBIVAX HB 40 MCG may include mild soreness or redness at the injection site. Some individuals might experience temporary fatigue or low-grade fever following vaccination. These effects are generally short-lived and resolve on their own.

RECOMBIVAX HB 40 MCG should be stored as directed to maintain its efficacy. It is important to inform healthcare providers of any allergies or medical conditions before administration. Follow the recommended schedule for optimal protection.

RECOMBIVAX HB 40 MCG may interact with certain medications or other vaccines. It is advisable to discuss current medications with a healthcare provider before receiving this vaccine. Avoid alcohol or other immune-suppressing substances around the time of vaccination.